Dictionary:
u·ro·ki·nase (yʊr'ō-kī'nās, -nāz) ![]() |
| 5min Related Video: urokinase |
| Sci-Tech Encyclopedia: Urokinase |
An enzyme that is a plasminogen activator. Urokinase cleaves the plasma protein plasminogen, forming the active enzyme plasmin, which subsequently degrades fibrin. Thus urokinase is an essential component in the fibrinolytic clot-dissolving system in the human body. See also Fibrinogen.
Urokinase is found in human urine and in much lower concentrations in human plasma. In the body, urokinase is produced by kidney cells, and its presence in the urine promotes the dissolution of any blood clots in the urine-collecting system of the kidneys or the bladder. Urokinase is also produced by a variety of tumor cells, and it is thought to be involved in the formation of tumor metastases. Urokinase can be inhibited by plasma inhibitor proteins. The presence of cell receptors and inhibitors suggests that the regulation of urokinase function is complex.
Urokinase is employed in clinical medicine in the treatment of venous blood clots (thrombophlebitis and pulmonary emboli), acute myocardial infarction, and arterial blood clots in the legs and arms. It is also used to prevent the accumulation of blood clots in intravenous catheters used to administer long-term chemotherapy. See also Blood; Enzyme; Plasmin.
| Dental Dictionary: urokinase |
An enzyme produced in the kidney and found in urine that is a potent plasminogen activator of the fibrinolytic system. A pharmaceutic preparation of urokinase is administered intravenously in the treatment of pulmonary embolism.
| Drug Info: Urokinase |
Brand names: Abbokinase®
Urokinase Solution for injection
What is this medicine?
UROKINASE breaks-up blood clots. It is used to treat large blood clots formed in the lungs.
This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.
What should I tell my health care provider before I take this medicine?
They need to know if you have any of these conditions:
•aneurysm
•bleeding problems or problems with blood clotting
•blood vessel disease or damaged blood vessels
•diabetic retinopathy
•head injury or tumor
•high blood pressure
•infection
•irregular heartbeats
•recent biopsy or surgery
•an unusual or allergic reaction to urokinase, other medicines, foods, dyes, or preservatives
•pregnant or trying to get pregnant
•breast-feeding
How should I use this medicine?
This medicine is for injection into a vein. It is given by a health care professional in a hospital or clinic setting.
Talk to your pediatrician regarding the use of this medicine in children. Special care may be needed.
Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.
NOTE: This medicine is only for you. Do not share this medicine with others.
What may interact with this medicine?
Do not take this medicine with any of the following medications:
•aminocaproic acid
•aprotinin
•tranexamic acid
This medicine may also interact with the following medications:
•antiinflammatory drugs, NSAIDs like ibuprofen
•aspirin and aspirin-like medicines
•dipyridamole
•drotrecogin alfa
•fish oil (omega-3 fatty acids) supplements
•ginkgo
•medicines that treat or prevent blood clots like warfarin, enoxaparin, and dalteparin
This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.
What should I watch for while using this medicine?
Your condition will be monitored carefully while you are receiving this medicine.
This medicine contains albumin from human blood. It may be possible to pass an infection in this medicine. Talk to your doctor about the risks and benefits of this medicine.
This medicine may increase your risk to bruise or bleed. Call your doctor or health care professional if you notice any unusual bleeding.
Do not take aspirin, ibuprofen, or other nonprescription pain relievers for several days after receiving this medicine.
What side effects may I notice from receiving this medicine?
Side effects that you should report to your doctor or health care professional as soon as possible:
•allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
•blue color to lips or nailbeds
•breathing problems
•changes in vision
•chest pain or tightness
•dark urine, stools, or vomit
•fast, irregular heartbeat
•fever, chills
•nausea, vomiting
•trouble passing urine or change in the amount of urine
•unusual bleeding, bruising, or purple spots on the skin
Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
•feeling faint or lightheaded
This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Where should I keep my medicine?
This drug is given in a hospital or clinic and will not be stored at home.
Last updated: 7/1/2002
Important Disclaimer: The drug information provided here is for educational purposes only. It is intended to supplement, not substitute for, the diagnosis, treatment and advice of a medical professional. This drug information does not cover all possible uses, precautions, side effects and interactions. It should not be construed to indicate that this or any drug is safe for you. Consult your medical professional for guidance before using any prescription or over the counter drugs.
| Sports Science and Medicine: urokinase |
An enzyme in urine that causes fibrinolysis.
| Veterinary Dictionary: urokinase |
An enzyme found in the urine of humans and other mammals which is secreted by kidney parenchymal cells and converts plasminogen to plasmin and activates the fibrinolytic system; used as a fibrinolytic agent.
| Wikipedia: Urokinase |
|
Urokinase
|
|
| Systematic (IUPAC) name | |
| Human urokinase | |
| Identifiers | |
| CAS number | 9039-53-6 |
| ATC code | B01AD04 |
| PubChem | ? |
| DrugBank | BTD00030 |
| Chemical data | |
| Formula | C1376H2145N383O406S18 |
| Mol. mass | 31126.5 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
|
plasminogen activator, urokinase
|
|
| Identifiers | |
| Symbol | PLAU |
| Entrez | 5328 |
| HUGO | 9052 |
| OMIM | 191840 |
| RefSeq | NM_002658 |
| UniProt | P00749 |
| Other data | |
| EC number | 3.4.21.31 |
| Locus | Chr. 10 q24 |
Urokinase (Abbokinase), also called urokinase-type Plasminogen Activator (uPA), is a serine protease (EC 3.4.21.73). Urokinase was originally isolated from human urine, but is present in several physiological locations, such as blood stream and the extracellular matrix. The primary physiological substrate is plasminogen, which is an inactive zymogen form of the serine protease plasmin. Activation of plasmin triggers a proteolysis cascade which, depending on the physiological environment participate in thrombolysis or extracellular matrix degradation. This links urokinase to vascular diseases and cancer.
Contents |
Urokinase is a 411 residue protein, consisting of three domains: the serine protease domain, the kringle domain and the growth factor domain. Urokinase is synthesized as a zymogen form (prourokinase or single chain urokinase), and is activated by proteolytic cleavage between L158 and I159. The two resulting chains are kept together by a disulfide bond.
The most important inhibitors of urokinase are the serpins plasminogen activator inhibitor-1 (PAI-1) and plasminogen activator inhibitor-2 (PAI-2), which inhibits the protease activity irreversibly. In the extracellular matrix urokinase is tethered to the cell membrane by its interaction to the urokinase receptor.
Elevated expression levels of urokinase and several other components of the plasminogen activation system are found to be correlated with tumor malignancy. It is believed that the tissue degradation following plasminogen activation, facilitates tissue invasion and thus contributes to metastasis. This makes urokinase an attractive drug target and inhibitors have been sought to be used as anticancer agents. However incompatibilities between the human and murine system hampers clinical evaluation of these agents. Through its interaction with the urokinase receptor, urokinase affects several other aspects of cancer biology such as cells adhesion, migration and cellular mitotic pathways.
Urokinase is used clinically as a thrombolytic agent in the treatment of severe or massive deep venous thrombosis, pulmonary embolism, myocardial infarction, and occluded intravenous or dialysis cannulas. It is also administered intrapleurally to improve the drainage of complicated pleural effusions and empyemas. Urokinase is presently marketed as KinlyticTM, and competes with AlteplaseTM as a thrombolytic drug in infarctation.
|
||||||||||||||||||||||
|
||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
| Fibrinogen Test: Precautions | |
| Thrombolytic Therapy | |
| Imarx Therapeutics Inc |
| Why is urokinase named urokinase? | |
| Does Urokinase declot a venous catheter? | |
| Is urokinase available in mercury drug store? |
Copyrights:
![]() | Dictionary. The American Heritage® Dictionary of the English Language, Fourth Edition Copyright © 2007, 2000 by Houghton Mifflin Company. Updated in 2009. Published by Houghton Mifflin Company. All rights reserved. Read more | |
![]() | Sci-Tech Encyclopedia. McGraw-Hill Encyclopedia of Science and Technology. Copyright © 2005 by The McGraw-Hill Companies, Inc. All rights reserved. Read more | |
![]() | Dental Dictionary. Mosby's Dental Dictionary. Copyright © 2004 by Elsevier, Inc. All rights reserved. Read more | |
![]() | Drug Info. Gold Standard. Copyright © 2008 by Gold Standard. All rights reserved. Read more | |
![]() | Sports Science and Medicine. The Oxford Dictionary of Sports Science & Medicine. Copyright © Michael Kent 1998, 2006, 2007. All rights reserved. Read more | |
![]() | Veterinary Dictionary. Saunders Comprehensive Veterinary Dictionary 3rd Edition. Copyright © 2007 by D.C. Blood, V.P. Studdert and C.C. Gay, Elsevier. All rights reserved. Read more | |
![]() | Wikipedia. This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article "Urokinase". Read more |
Mentioned in